Concepedia

Jade Homsi

JH

44

Publications

5.8K

Citations

29

H-Index

2000

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Cleveland Clinic

The University of Texas Southwestern Medical Center

Moffitt Cancer Center

Regeneron (United States)

Jade Homsi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2000–2023

44

Publications

44

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, John M. Kane, Mark Agulnik et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.1K citations · Full text

, , +15

Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Laszlo Radvanyi, Chantale Bernatchez, Minying Zhang et al. · Clinical Cancer Research · 2012 · 426 citations · Full text

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

Margaret von Mehren, John M. Kane, Marilyn M. Bui et al. · Journal of the National Comprehensive Cancer Network · 2020 · 296 citations

, , +16

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · New England Journal of Medicine · 2022 · 288 citations · Full text

Rows per page

1–5 of 44